0
Your cart

Your cart is empty

Books > Business & Economics

Buy Now

Science Business - The Promise, The Reality, And The Future Of Biotech (Hardcover) Loot Price: R743
Discovery Miles 7 430
You Save: R151 (17%)

Science Business - The Promise, The Reality, And The Future Of Biotech (Hardcover)

Gary P Pisano

 (sign in to rate)
List price R894 Loot Price R743 Discovery Miles 7 430 | Repayment Terms: R70 pm x 12* You Save R151 (17%)

Bookmark and Share

Expected to ship within 10 - 15 working days

The biotech industry constitutes one of the most profound experiments of our time. It is a global-scale effort to take fundamental advances in bio-sciences and convert them into successful businesses that add value to our economy and enhance our health and quality of life. But so far, the grand promise of this industry has not been fulfilled, and there is a general acknowledgment that the sector has failed to perform up to expectations. Why? Gary Pisano, who has spent virtually his entire career studying various aspects of the biotech and pharmaceutical industries, makes a compelling argument that this failure is due to the special character of biotech as a science-based business, and gives a clear-eyed and provocative assessment of deep flaws in the industry resulting from the clash of the distinct realms of science and business. In particular, he identifies three salient characteristics of drug science that create unique business challenges: drug science is characterized by profound uncertainty and long time horizons for R&D - so how do you finance investments under these conditions? drug science knowledge is accumulating at an extremely rapid pace, and builds cumulatively in w scientific revolutions - so how do you integrate efforts across a broad spectrum of scientific and technological capabilities? The author then turns to prescription, arguing that the key to fixing the industry lies in funding arrangements and arrangements for monetizing intellectual property. This is truly our most contemporary and complex industry, integrally involving biotech firms, investors, universities, established pharmaceutical companies, government regulators, and other players. Pisano argues, compellingly, that the stakes for righting the industry are too high to ignore, with not only the fate of the biotech and pharma industries on the line, but also health care and, indeed, the future of human health.

General

Imprint: Harvard Business School Press
Country of origin: United States
Release date: November 2006
First published: 2007
Authors: Gary P Pisano
Dimensions: 236 x 160 x 22mm (L x W x T)
Format: Hardcover
Pages: 237
ISBN-13: 978-1-59139-840-0
Categories: Books > Business & Economics > General
Promotions
LSN: 1-59139-840-1
Barcode: 9781591398400

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners